ABH

Overview

ABH is an orally active arginase inhibitor ( K i = 8.5 nM). ABH promotes NO production and reduces the expression of inflammatory response-related molecules ( ICAM-1 , VCAM-1 , MCP-1 ). ABH improves erectile function, reduces lung damage, promotes wound healing, reduces arterial blood pressure, and improves vascular fibrosis.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Arginase

Product Information

• Catalog No.: HY-112868A
• CAS No.: 222638-65-5
• Molecular Formula: C6H14BNO4
• Molecular Weight: 174.99
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source